Cancer Medicine


Publication Venue For

  • Recent survival trends in diffuse large B-cell lymphoma––Have we made any progress beyond rituximab?.  9:5519-5525. 2020
  • Race, tumor location, and disease progression among low-risk prostate cancer patients.  9:2235-2242. 2020
  • A rigorous exploration of anal HPV genotypes using a next-generation sequencing (NGS) approach in HIV-infected men who have sex with men at risk for developing anal cancer.  9:807-815. 2020
  • Health care-related time costs in patients with metastatic breast cancer 2020
  • Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.  8:7833-7845. 2019
  • Healthy lifestyle discussions between healthcare providers and older cancer survivors: Data from 12 cancer centers in the Southeastern United States.  8:7123-7132. 2019
  • Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy.  8:6915-6922. 2019
  • Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.  8:2503-2513. 2019
  • The impact of structural factors on diagnostic delay in diffuse large B-cell lymphoma.  8:1416-1422. 2019
  • Factors associated with physical inactivity in adult breast cancer survivors—A population-based study.  7:6331-6339. 2018
  • Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.  7:1183-1193. 2018
  • Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.  7:616-625. 2018
  • Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.  6:2142-2152. 2017
  • Out-of-pocket costs and burden among rural breast cancer survivors.  6:572-581. 2017
  • CXCL9: evidence and contradictions for its role in tumor progression.  5:3246-3259. 2016
  • An examination of racial differences in 5-year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010.  5:2126-2135. 2016
  • Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.  5:1526-1534. 2016
  • Recreational physical activity and ovarian cancer risk in African American women.  5:1319-1327. 2016
  • Associations between advanced cancer patients' survival and family caregiver presence and burden.  5:853-862. 2016
  • Associations Between Presence and Burden of Family Caregivers and Advanced Cancer Patients Survival 2016
  • Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in acolon-26 tumor-bearing mouse model in vivo.  4:1767-1780. 2015
  • A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.  3:988-997. 2014
  • Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer.  2:925-932. 2013
  • Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.  2:734-743. 2013
  • Electronic International Standard Serial Number (eissn)

  • 2045-7634